Galectin Therapeutics (GALT) Minority Interest (2015 - 2016)

Galectin Therapeutics' Minority Interest history runs 2 years deep, the most recent figure standing at $1.7 million for Q3 2016.

• In Q3 2016, Minority Interest changed N/A year-over-year to $1.7 million; the TTM figure through Sep 2016 stood at $1.7 million (changed N/A YoY), while the FY2015 annual figure was $1.7 million, changed N/A from the prior year.
• Minority Interest for Q3 2016 stood at $1.7 million, roughly flat from $1.7 million in the prior quarter.
• The five-year high for Minority Interest was $1.7 million in Q4 2015, with the low at $1.7 million in Q4 2015.